1. "Body Imaging Service"
Formats
  1. Journal Article (1718)
  2. Meeting Abstract (519)
  3. Review (163)
  4. Book Section (128)
  5. Conference Paper (43)
  6. Editorial (35)
  7. Guidelines (29)
  8. Miscellaneous (16)
  9. Correspondence (11)
  10. Book Whole (5)
  11. Research Letter (4)
Groups
  1. Body Imaging Service (2671)
  2. Radiology, Department of (2670)
  3. Department of Medicine (992)
  4. Solid Tumor Oncology Division (875)
  5. Surgery (752)
  6. Epidemiology and Biostatistics (734)

More Groups

People
  1. Lawrence Schwartz (306)
  2. Oguz Akin (264)
  3. Kinh Gian Do (256)
  4. Michelle Ginsberg (235)
  5. Marc Gollub (208)
  6. Hedvig Hricak (158)

More People

Years
  1. 2025 (69)
  2. 2024 (169)
  3. 2023 (220)
  4. 2022 (200)
  5. 2021 (189)
  6. 2020 (165)

More Years

Publications
  1. Journal of Clinical Oncology (322)
  2. American Journal of Roentgenology (147)
  3. Radiology (122)
  4. Abdominal Radiology (84)
  5. European Radiology (67)
  6. Clinical Cancer Research (65)

More Publications

Publishers
  1. Springer (359)
  2. American Society of Clinical Oncology (346)
  3. Elsevier Inc. (316)
  4. American Roentgen Ray Society (147)
  5. Radiological Society of North America, Inc. (141)
  6. Elsevier Science, Inc. (128)

More Publishers

Results (2671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world experience and molecular features of response to immune checkpoint blockade in patients with recurrent small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Ginsberg, M. S.; Kris, M. G.; Beras, A.; Rekhtman, N.; Poirier, J. T.; Hellmann, M. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Improving risk assessment of obesity-associated breast cancer
    Meeting Abstract

    Iyengar, N. M.; Gucalp, A.; Zhou, X. K.; Wang, H.; Giri, D. D.; Williams, S.; Falcone, D. J.; Winston, L.; Landa, J.; Kirstein, L. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC) - First experimental arm (EA) initial results
    Meeting Abstract

    George, T. J.; Yothers, G.; Hong, T. S.; Russell, M. M.; You, Y. N.; Parker, W.; Jacobs, S. A.; Lucas, P. C.; Gollub, M. J.; Hall, W. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)
    Meeting Abstract

    Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save